Sort   by:  
 Page size 
UnknownSerial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease.
Not available
S-EPMC2677798 | biostudies-literature
UnknownGlucose metabolism in posterior cingulate cortex has supplementary value to predict the progression of cognitively unimpaired to dementia due to Alzheimer's disease: an exploratory study of 18F-FDG-PET.
Not available
S-EPMC10828178 | biostudies-literature
UnknownA phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease.
Not available
S-EPMC2790221 | biostudies-literature
UnknownA data-driven examination of apathy and depressive symptoms in dementia with independent replication.
Not available
S-EPMC9899765 | biostudies-literature
UnknownGlucose metabolism patterns: A potential index to characterize brain ageing and predict high conversion risk into cognitive impairment.
Not available
S-EPMC9616982 | biostudies-literature
UnknownA composite score for executive functioning, validated in Alzheimer's Disease Neuroimaging Initiative (ADNI) participants with baseline mild cognitive impairment.
Not available
S-EPMC3684181 | biostudies-literature
UnknownMild cognitive impairment with suspected nonamyloid pathology (SNAP): Prediction of progression.
Not available
S-EPMC4336071 | biostudies-literature
UnknownA randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease.
Not available
S-EPMC4626244 | biostudies-literature
UnknownA phase II trial of huperzine A in mild to moderate Alzheimer disease.
Not available
S-EPMC3269774 | biostudies-literature
UnknownAntioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures.
Not available
S-EPMC3661272 | biostudies-literature
Sort   by:  
 Page size